Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma. Zong JF, Liang QD, Lu QJ, Liu YH, et al. BMC Cancer 2021;21:1274.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zong JF, Liang QD, Lu QJ, Liu YH, et al. Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma. BMC Cancer 2021;21:1274.
PMID: 34823489